Author: admin

$RWAS Lists on ByTrade and Gives Away 50,000 Tokens

RWA Finance, a leading platform in tokenizing real-world assets into digital tokens on the blockchain, has achieved another milestone by listing its $RWAS token on ByTrade.

This launch is set to enhance liquidity and broaden RWA Finance’s visibility, marking a significant step forward in the tokenization of real-world assets and global trading opportunities. The $RWA token is now available for trading on ByTrade, thereby providing users with seamless access to RWA Finance’s innovative platform for trading and arbitrage.

ByTrade, a rapidly expanding ecosystem known for its low crypto transaction fees and authentic token offerings, is dedicated to providing a secure and accessible trading environment for traders in the crypto and web3 sectors.

An Overview of RWA Finance

RWA Finance facilitates the tokenization of real-world assets, enabling seamless global trading and arbitrage opportunities. Through the use of blockchain technology, RWA Finance offers mobile accessibility and liquidity, supported by the 1inch Protocol across over 10 networks and 1000 trading pools with liquidity exceeding $100 million.

The platform prioritizes user engagement with advanced risk control, user-friendly trading interfaces, staking options, and governance rights for RWA token holders.

What Problem is RWA Finance Solving?

The current financial landscape often faces challenges in accessing and trading real-world assets. RWA Finance addresses these challenges by providing a platform that tokenizes real-world assets, making them easily tradable and accessible to a global audience.

By leveraging blockchain technology, RWA Finance ensures transparency, security, and efficiency in the trading of real-world assets, revolutionizing the traditional financial ecosystem.

After this listing, RWA Finance will be giving out 50,000 RWAS tokens as airdrops for users participating in this event.

How To Participate in the Airdrop

Follow these 3 steps to participate:

  1. Register for a ByTrade account and complete the verification process.
  2. Accumulate deposits totaling $100 worth of RWAS, or deposit 100 USDT and buy RWAS to complete your initial spot transaction.
  3. Search for posts made by @RWA_Finance_, @bytradeio, or Key Opinion Leaders (KOL) and engage by leaving a comment promoting RWAS.

After promoting, take a screenshot of your engagement, share it within the official Telegram community, and then upload it through the provided form.

About ByTrade

ByTrade is a rapidly expanding futures and spot trading platform at the forefront of change in the crypto and web3 sectors. ByTrade is dedicated to providing a secure and accessible trading environment for traders.

Apart from trading, ByTrade opens doors to the captivating world of Initial Exchange Offerings (IEOs) and the chance to participate in airdrops featuring newly minted tokens.

However, ByTrade’s vision extends beyond trading – the platform is committed to unlocking the full potential of web3 by nurturing projects with extraordinary potential within its team and ecosystem. This commitment places ByTrade at the forefront of the crypto revolution.

For more information about ByTrade: Twitter | Facebook| Instagram | Telegram chat | Telegram channel | Blog | Linktree.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: ByTrade
Contact Person: Tarek Al Fakih
Email: Send Email
City: Dubai
Country: United Arab Emirates
Website: https://www.bytrade.io/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: $RWAS Lists on ByTrade and Gives Away 50,000 Tokens

Param Labs and Animoca Brands partner to innovate and advance gaming industry in MENA and beyond

Param Labs, a leader in game and technology development, and Animoca Brands, the company advancing digital property rights for gaming and the open metaverse, today announced a strategic partnership to leverage Animoca Brands’ expertise to bolster Param Labs’ go-to-market strategy, particularly in the area of launching innovative Web3 products, and to refine Param Labs’ blockchain and token economy design. 

Param Labs is an Abu Dhabi-based development studio focused on developing video games and infrastructure to power the next generation of gaming. Some of its notable products include Kiraverse, a Web3 TPS, and Pixel To Poly, the leading platform for transforming 2D NFTs into 3D game-ready files for use in GTA V, Fortnite Creative Mode, and beyond.  

As part of the partnership, Param Labs is introducing its Pixel To Poly platform to selected Animoca Brands’ projects and portfolio companies, enabling the transformation of 2D art into 3D game-ready assets. This service aims to revolutionize game asset creation by using AI to streamline the transition to advanced design dimensions.

Param Labs is preparing for several exciting initiatives, including a free-mint NFT launch and the release of its litepaper, which will detail its game economy and infrastructure. This includes a network of Layer 2 and Layer 3 solutions with parallelized VMs such as Move and SVM, leveraging Param Labs’ innovative Web3 framework utilizing modular blockchain architecture.

This collaboration signifies a major leap for Param Labs and the broader Web3 gaming ecosystem in MENA. With Animoca Brands’ support, Param Labs is well positioned to break new ground in the Web3 and gaming sectors.

Anthony Anderson, founding partner of Param Labs, commented: “We’re thrilled to announce a partnership that accelerates Param Labs and the entire gaming industry. United with Animoca Brands by a shared vision of ensuring gamers derive true value from their gaming experiences, this collaboration marks a pivotal step in redefining the gaming landscape.”

Yat Siu, co-founder and executive chairman of Animoca Brands, commented: “We’re excited to partner with Param Labs to advance digital property rights in gaming, bringing us a step closer to realizing the vision of the truly open metaverse. This collaboration aligns with our shared vision to redefine the gaming landscape, ensuring that gamers are the true owners of their digital assets. Together, we’re working to transform the industry, emphasizing the value of gamer experiences and ownership.” 

About Param Labs

Param Labs is at the forefront of leveraging artificial intelligence and blockchain technologies to advance the rapidly growing $200B+ gaming industry. By addressing some of the most significant challenges believed to limit the sector’s long-term growth, Param Labs is setting new standards for innovation and user engagement. Its ecosystem is crafted to provide gamers with digital ownership over their gaming assets, and to enable the creation of user-generated value across their experiences. With a keen focus on solving apparent issues in the gaming world, Param Labs designs products that not only aim to seamlessly integrate millions of new users into the benefits of Web3 technology but also to empower individual creators and studios. The team is dedicated to developing the necessary tools for effortlessly utilizing the advantages of emerging technologies, paving the way for the future of the gaming industry. Through its efforts, Param Labs is positioned as a pivotal player in transforming how gamers interact with digital content, promoting a more inclusive and dynamic gaming environment. To learn more visit www.paramlabs.io or follow on X (Twitter).

About Animoca Brands

Animoca Brands, a Deloitte Tech Fast winner, a Fortune Crypto 40 company, and one of the Financial Times’ High Growth Companies Asia-Pacific 2023, is a Web3 leader that leverages blockchain to deliver digital property rights to consumers around the world to help to establish the open metaverse. The company develops and publishes a broad portfolio of products including original games such as The Sandbox, PHANTOM GALAXIES™, Life Beyond, and Crazy Defense Heroes, and products utilizing popular intellectual properties from the worlds of sports and entertainment, such as The Walking Dead, Power Rangers, MotoGP™, and Formula E. It has multiple subsidiaries, including The Sandbox, Blowfish Studios, Quidd, GAMEE, nWay, Pixowl, Forj, Lympo, Animoca Brands Japan, Grease Monkey Games, Eden Games, Darewise Entertainment, Notre Game, TinyTap, Be., PIXELYNX, WePlay Media, Gryfyn, and Azarus. Animoca Brands is one of the most active investors in Web3, with a portfolio of over 400 Web3 investments, both directly and through Animoca Ventures, including Yuga Labs, Axie Infinity, Polygon, Consensys, Fireblocks, OpenSea, Dapper Labs, Yield Guild Games, and many more. For more information visit www.animocabrands.com or follow on X (Twitter) or Facebook.

Contacts

Param Labs: support@paramlabs.io

Animoca Brands: press@animocabrands.com

Media Contact
Company Name: Param Labs
Contact Person: DVerse
Email: Send Email
City: Abu Dhabi
Country: United Arab Emirates
Website: https://paramlabs.io/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Param Labs and Animoca Brands partner to innovate and advance gaming industry in MENA and beyond

Silicone Surfactants Market Graph, Segmentations, Growth, Key Developments, Opportunities, Applications, Regional Analysis and Forecast Report

“Browse 106 market data Tables and 28 Figures spread through 149 Pages and in-depth TOC on “Silicone Surfactants Market””
Silicone Surfactants Market by Application (Emulsifiers, Foaming Agents, Defoaming Agents, Wetting Agents, Dispersants), End-Use Industry (Personal Care, Construction, Textile, Paints & Coatings, Agriculture), and Region

The report “Silicone Surfactants Market by Application (Emulsifiers, Foaming Agents, Defoaming Agents, Wetting Agents, Dispersants), End-Use Industry (Personal Care, Construction, Textile, Paints & Coatings, Agriculture), and Region – Global Forecast to 2024″ The silicone surfactants market is estimated to be USD 2.0 billion in 2019 and is projected to reach USD 2.5 billion by 2024, at a CAGR of 5.0% from 2019 to 2024. The growth of the silicone surfactants market can be attributed to the increasing demand for silicone surfactants from the end-use industries. Stringent environmental regulations against the use of conventional surfactants provide a prospect for growth to the silicone surfactants market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=192476281 

Personal care end-use industry segment accounts for the largest share of the silicone surfactants market

The personal care segment is the largest contributor to the global silicone surfactants market in terms of value. The personal care industry consumes more than one-third of the global silicone surfactants produced. The growth of the personal care segment can be attributed to the increasing use of silicone surfactants in skincare, haircare, and personal hygiene products. Growing demand for personal care products from emerging economies, such as China and India, is fueling the growth of the personal care industry.

Based on application, the emulsifiers segment is projected to be the highest revenue generator of the silicone surfactants market by 2024

The emulsifiers application segment is estimated to lead the silicone surfactants market in 2019, and this trend is expected to continue during the forecast period as well. The growth of this segment can be attributed to the increasing use of silicone surfactants in the personal care, construction, and paints & coatings industries. Features such as stabilization, spreadability, and softness make silicone surfactants preferable for use as emulsifiers in personal care products, polyurethane foams, and coatings, among other applications.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=192476281 

The Europe region is expected to lead the silicone surfactants market during the forecast period

The European region is estimated to lead the silicone surfactants market in 2019 and is expected to continue its dominance in the near future. The upsurge in the number of working women and increasing e-commerce activities have led to the rise in demand for personal care products in this region. The high demand for silicone surfactants from the personal care industry in countries, such as Germany, the UK, and France, is a key factor driving the growth of the European silicone surfactants market.

Major companies operating in the silicone surfactants market include Evonik Industries AG (Germany), Dow Corning Corporation (US), Momentive Performance Materials Inc. (US), Wacker Chemie AG (Germany), Innospec Inc. (US), Shin-Etsu Chemical Co., Ltd. (Japan), Siltech Corporation (Canada), Elé Corporation (US), Elkem ASA (France), Supreme Silicones (India), Silibase Silicone New Material Manufacturer Co., Ltd. (China), Jiangsu Maysta Chemical Co., Ltd. (China), Elkay Chemicals Pvt. Ltd. (India), Hangzhou Ruijiang Performance Material Science Co., Ltd. (China), Harcros Chemicals Inc. (US), and SST Australia Pty Ltd. (Australia). These companies have principal operations in the Asia Pacific, North American, and European regions. They undertake organic and inorganic expansion strategies to increase their market shares. Expansion is an essential strategy in this market to cater to competitive products to the end-user industries.

Momentive Performance Materials (US) is one of the leading manufacturers of silicone surfactants. The company has strong product offerings which are distributed across various regions, such as North America, Asia Pacific, and Europe. The company is primarily focused on inorganic growth strategies, such as acquisition to enhance its product portfolio.

  • The Investor Group (involves SJL Partners, KCC Corporation, and Wonik QnC Corporation) acquired Momentive Performance Chemicals. This acquisition is expected to strengthen the position and geographic reach of Momentive Performance Chemicals. It will also expand the product portfolio and financial position of the company.

Innospec Inc. (US) is engaged in manufacturing and distributing specialty chemicals. It operates through product segments, namely, fuel specialties, performance chemicals, oilfield services, and octane additives. The company caters its products to industries, such as personal care, home care, agrochemical, and mining. The company offers silicone surfactants under the performance chemicals segment. These surfactants are used in the personal care industry. The company has a presence in around 23 countries across the Americas, Europe, the Middle East, Africa, and Asia Pacific.

  • In 2019, Innospec made a series of investments to further expand its capabilities in research, development, and technical services for its Performance Chemicals business.
  • Further, in January 2017, Innospec established a wholly-owned enterprise in China. The subsidiary enhances the company’s business in the Asian market.

Read Our Trending Press Release Below:

Barrier Films Market

Biosurfactants Market

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/silicone-surfactant-market-192476281.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Silicone Surfactants Market Graph, Segmentations, Growth, Key Developments, Opportunities, Applications, Regional Analysis and Forecast Report

Food Grade Gases Market Analysis, Trends, Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast – 2027

“MarketsandMarkets™”
Food Grade Gases Market by Type (Nitrogen, Oxygen, Carbon Dioxide), Application (Freezing & Chilling, Packaging, Carbonation), Industry (Dairy & Frozen Products, Beverages, Meat, Poultry & Seafood) and Region – Global Forecast to 2027

The food grade gases market size is estimated to be valued at USD 7.6 billion in 2022. It is projected to reach USD 10.6 billion by 2027, recording a CAGR of 6.9% during the forecast period. Food-grade gases are defined as gases used as a processing aid or as an additive in the food & beverage industry. These gases should comply with the standards set by regulatory bodies such as the FDA. They are used alone or in combination for freezing & chilling, packaging, and for carbonation in certain beverages. Some of the most commonly used food-grade gases include carbon dioxide, nitrogen, oxygen, hydrogen, and argon. These gases are used for multiple end-uses such as meat, poultry, and seafood products, beverages, dairy & frozen food products, and convenience food products.

Food Grade Gases Market

Food Grade Gases Market Trends

1. Increasing Demand for Convenience Foods: With a rise in urbanization and busy lifestyles, there has been a growing demand for convenience foods. Food-grade gases, such as nitrogen and carbon dioxide, play a crucial role in food processing and packaging, helping to extend the shelf life of products.

2. Focus on Food Safety and Quality: Food safety and quality have become paramount concerns for both consumers and regulatory bodies. The use of food-grade gases in modified atmosphere packaging (MAP) and controlled atmosphere storage (CAS) has gained traction as it helps in preserving the freshness of food products, reducing the risk of contamination, and maintaining product quality.

3. Technological Advancements in Cold Chain Storage: Advancements in cold chain storage and transportation technologies have driven the demand for food-grade gases. These gases are essential for maintaining the required temperatures during the storage and transportation of perishable goods, preventing spoilage, and ensuring food safety.

4. Rising Awareness of Sustainable Packaging: There is an increasing awareness and emphasis on sustainable packaging solutions in the food industry. Food-grade gases are being utilized in sustainable packaging methods, such as using nitrogen to displace oxygen in packaging to prolong the shelf life of products without the need for preservatives.

5. Global Expansion of Food Processing Industry: The global expansion of the food processing industry, especially in emerging markets, has contributed to the growth of the food-grade gases market. These gases are used in various stages of food processing, from freezing and chilling to carbonation in beverages.

6. Stringent Regulations and Standards: Regulatory bodies have implemented stringent standards and regulations related to food safety and quality. This has led food manufacturers to adopt technologies, including the use of food-grade gases, to comply with these standards and ensure the production of safe and high-quality food products.

7. Innovation in Gas Packaging Technologies: Ongoing research and development efforts have been directed towards innovating new gas packaging technologies. This includes the development of advanced MAP and CAS systems, as well as the exploration of novel gases for specific applications in food preservation.

Food Grade Gases Market Opportunities: Increasing consumer preference for frozen and chilled food products to propel the market demand

The increasing popularity of shelf-stable foods among consumers on a global level is expected to propel the demand for frozen and chilled food products over the next few years. According to an article published in Progressive Grocer in August 2021, the popularity of these foods including breakfast meals rose by 10.9%, and dinners/entrees were up by 4.9%. frozen meat, up 2.7%, and processed chicken (up 10.4%). Moreover, the utilization of these products by numerous end users such as full-service restaurants, hotels & resorts, and quick-service restaurants will further support the growth of this market.

Increasing demand for frozen sea food in countries away from the coast are escalating the market for food-grade gases. Additionally, the market is also expected to expand due to the increasing import and export of various packaged food products. For instance, in October 2021, Amul, the Indian food retailer expanded its frozen and ready-to-eat food offerings including food such as frozen potatoes, paneer, cheese parathas, and patties.

This growth is also fuelled by new legislation in the retail environment, which gives foreign investors and multinational retail chains access to these markets. These retail chains have organized distribution channels across these markets, which provides opportunities for setting up food & beverage industries here. The growing importance of food safety and the quality of processed foods in these countries has increased the need to prevent the deterioration of food with the use of proper packaging technologies, which has increased investments in refrigerated storage facilities.

North America is projected to reach USD 3.4 Billion during the forecast period.

Key countries identified in the North American food-grade gases market include the US, Canada, and Mexico. The North American food-grade gases market is projected to witness significant growth due to the huge pork and beef industry and the increasing consumption of RTE and bakery food products. According to the United States Department of Agriculture (USDA), there were about 38,000 food processing and manufacturing companies present in the US in 2019. This growing food & beverage processing sector in the US is expected to fuel the demand for food-grade gases, especially for packaging and carbonation. According to a report published by the Commission for Environmental Cooperation (Canada) in 2017, about 168 million tons of food is wasted or lost in North America every year. Food-grade gases such as nitrogen serve as a cheaper preservative that enhances the shelf life of food products by keeping oxygen out and preventing spoilage.

Food Grade Gases Market Share

The key players in this market include Air products & Chemicals, Inc. (US), Cryogenic Gases (US), American Welding & Gas (US).

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/food-grade-industrial-gases-market-9473111.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Food Grade Gases Market Analysis, Trends, Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast – 2027

Food Flavors Market Analysis, Trends, Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast – 2027

“MarketsandMarkets™”
Food Flavors Market by Labelling/ Regulation (Natural, Nature Identical/ Artificial), Form (Liquid & Gel, Dry), Type (Chocolate & Brown, Vanilla, Fruit & Nut, Spices & Savory, Dairy), Application (Food, Beverage) Region – Forecast 2027

The global food flavors market size is predicted to grow at a CAGR of 3.5% between 2022 and 2027, reaching a value of $21.3 billion by 2027 from a projection of $18.0 billion in 2022. Convenience is a prime concern for present-day consumers, who frequently lack time to make wholesome food and beverages at home due to cultural upheavals and dynamic lifestyle changes. Hesitant to forgo nutrition, they seek ready-made substitutes that can save time without jeopardizing their health objectives.

Food Flavors Market

However, there is much loss of natural food flavors as convenience foods undergo extensive processing. To compensate for this loss, manufacturers are widely employing food flavors, both natural and artificial, to improve the overall aroma of food and beverages, hence fueling the expansion of the food flavor market. At the same time, constant innovations, increased investment in R&D, and a surging demand for variety in foods and beverages have led to extensive use of flavors by producers. Flavors can be created synthetically or can be derived naturally from fruits, botanical extracts, meat, spices, herbs, and essential oils.

Food Flavors Market Trends

1. Natural Flavors Dominance: Consumers continue to show a preference for natural flavors over artificial ones. There has been a growing demand for food products with clean labels, leading to an increased use of natural ingredients and flavors derived from fruits, vegetables, herbs, and spices.

2. Health and Wellness Focus: With an increasing awareness of health and wellness, there has been a surge in demand for functional flavors. This includes flavors with perceived health benefits, such as those associated with antioxidants or other bioactive compounds.

3. Exotic and Ethnic Flavors: Consumers are increasingly adventurous when it comes to food, leading to a rise in the popularity of exotic and ethnic flavors. Unique and authentic tastes from different regions around the world are finding their way into mainstream food products.

4. Plant-Based and Vegan Flavors: The growing trend toward plant-based and vegan lifestyles has influenced the food flavors market. Plant-based flavors, especially those mimicking meat and dairy, are in high demand as consumers seek alternatives that align with their dietary choices.

5. Innovation in Savory Flavors: There has been significant innovation in savory flavors, with a focus on umami and bold taste profiles. This extends to snack foods, ready meals, and other savory applications.

6. Customization and Personalization: Companies are increasingly offering customizable and personalized flavor options to cater to individual preferences. This can include the ability to mix and match flavors or even create unique blends.

7. Clean Label and Transparency: Consumers are becoming more conscious of the ingredients in their food, leading to a demand for clean label products. Brands are responding by providing transparent information about the sourcing and composition of their flavorings.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=93115891

A shift in demand for natural and sustainable flavors

The consumer demand for international flavors has been sparked by aggressive marketing tactics, globalization, and market liberalization. Consumers want to experience a variety of flavors and cuisines that claim to be “natural” and “safe” without expending excessive time and effort. As a result, there is a greater demand for natural flavors, which has led to the introduction of new flavor-infused goods. Many consumers express interest in unexpected flavors presented in well-known forms and are willing to test new flavors accompanied by detailed label descriptions. According to the International Food Information Council’s (IFIC) June 2021 survey, 64% of adults in the US claim that they tend to prioritize foods made with clean ingredients, and 63% of adults report that the ingredients in a food or beverage have a moderate influence on their purchasing decision. The report further reveals that 48% of consumers seek foods that contain natural flavors. Based on the IFIC’s 2021 Food and Health Survey, 20% of American consumers also report routinely purchasing foods and beverages that claim clean ingredients on the food label. The demand for natural flavors is rising as customers increasingly choose meals and beverages with natural tastes and product formulations for health advantages, from blueberry-flavored protein drinks to chocolate- and rose-flavored teas.

Food Flavors Market Share

The key players in the food flavors industry include Givaudan (Switzerland), International Flavors and Fragrances (IFF) (US), Symrise (Germany), Firmenich (Switzerland), and Mane (France).

North America dominated the food flavors market in 2021

North America is the largest market for food flavors owing to the growing demand for processed and functional food products influenced by the hectic lifestyle and changing eating habits of the consumers in this region. The growth could be attributed to its ever-expanding food & beverage processing industry and the increasing popularity of functional foods. North America harbors some of the leading food and beverage manufacturing companies, such as ADM, Sensient, and Synergy Flavors, continuously upgrading their product portfolios to maintain their position as key players in the food flavors market, boosting the growth of the same. Presence of companies such as ADM (US), International Flavors & Fragrances Inc. (US), Sensient Technologies Corporation (US), Synergy Flavors, Inc. (US) in the North American region contributes to the dominant position of the region.

Key Questions Addressed by Food Flavors Market Report:

1. Which region is projected to account for the largest share of the food flavors market?

2. What is the forecasted size of the global food flavors market?

3. Which food flavor types are considered in the study and which segments are projected to have promising growth rates in the future?

4. Which are the key players in the food flavors market?

5. What kind of information is provided in the competitive landscape section?

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/food-flavors-market-93115891.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Food Flavors Market Analysis, Trends, Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast – 2027

Agriculture Drones Market Analysis, Trends, Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast – 2028

“MarketsandMarkets™”
Agriculture Drones Market by Offering (Hardware, Software and Services), Components, Payload Capacity, Medium-weight drones, Heavy-weight drones, Farming Environment, Application, Farm Produce, Range, Farm Size and Region – Global Forecast to 2028

The agriculture drones market size is predicted to grow at a CAGR of 31.5% between 2023 and 2028, reaching a value of $17.9 billion by 2028 from a projection of $4.5 billion in 2023. Drone technologies are quickly revolutionizing the agricultural sector owing to the recent evolutions in this technology and the Federal Aviation Administration (FAA) regulations, thereby bringing drones into mainstream farming. With the global population projected to reach over 9 billion by 2050, the consumption of agricultural products is expected to increase by 70%, a figure complicated by unpredictable weather patterns and natural disasters.

Agriculture Drones Market

What are agriculture drones?

Agriculture drones, also known as agricultural UAVs (Unmanned Aerial Vehicles) or ag drones, are remotely piloted or autonomous aerial vehicles designed specifically for use in farming and agriculture. These drones are equipped with various sensors, cameras, and other technologies to collect data and perform tasks aimed at improving crop management, yield optimization, and overall farm efficiency. Agriculture drones have gained popularity due to their ability to provide farmers with valuable insights and data-driven solutions.

Key features and applications of agriculture drones include:

Remote Sensing: Drones can carry sensors that capture data such as infrared imagery, multispectral images, and thermal images. These data can be used to assess crop health, identify areas with pest infestations or diseases, and monitor overall plant conditions.

Precision Agriculture: Drones enable precision farming by allowing farmers to target specific areas of their fields with the precise application of resources like fertilizers, pesticides, and water. This targeted approach helps optimize resource usage and reduce environmental impact.

Mapping and Surveying: Drones equipped with mapping and surveying tools can create detailed 3D maps of the farmland. This information aids in better land management, irrigation planning, and drainage optimization.

Crop Monitoring: Drones can regularly monitor crop growth and development, providing real-time data on crop health and identifying potential issues early on. This helps farmers make informed decisions regarding irrigation, nutrient application, and pest control.

Planting and Seeding: Some specialized drones are designed for planting seeds in a precise and controlled manner. This can enhance the efficiency of the planting process and contribute to optimal spacing and germination.

Livestock Monitoring: Drones are also used in livestock management by providing aerial views for monitoring herd health, assessing pasture conditions, and identifying potential issues in the field.

Weather and Climate Monitoring: Drones equipped with weather sensors can collect data on temperature, humidity, and other atmospheric conditions. This information is valuable for understanding local weather patterns and making informed decisions about crop management.

Agriculture Drone Market Trends

Precision Agriculture Adoption: Agriculture drones were increasingly being used for precision farming. These drones are equipped with various sensors and imaging technologies, such as NDVI (Normalized Difference Vegetation Index) cameras, to monitor crop health, assess soil conditions, and optimize resource utilization.

Automation and AI Integration: Drones with advanced automation features and artificial intelligence (AI) integration were gaining popularity. These capabilities allowed drones to autonomously navigate fields, analyze data in real-time, and make informed decisions for optimizing farming practices.

Data Analytics and Decision Support: The emphasis was on leveraging the vast amounts of data collected by agriculture drones. Data analytics tools and platforms were being used to process drone-collected information, providing farmers with valuable insights for better decision-making in areas such as crop management, yield prediction, and resource allocation.

Crop Monitoring and Disease Detection: Agriculture drones were increasingly employed for crop monitoring and early detection of diseases. High-resolution imagery and sensors allowed farmers to identify potential issues in crops, enabling timely interventions to prevent widespread damage.

Integration with Other Technologies: Agriculture drones were being integrated with other emerging technologies such as Internet of Things (IoT) devices, satellite imaging, and farm management software. This integration aimed to create a comprehensive and interconnected farming ecosystem.

Regulatory Developments: The regulatory environment for drone usage in agriculture was evolving. Governments were working on defining guidelines and regulations to ensure safe and responsible drone operations in agricultural settings. Compliance with these regulations became a significant consideration for industry players.

Customization for Specific Crops: Drone manufacturers were focusing on designing specialized drones tailored to the needs of specific crops. Different crops may require unique monitoring parameters and sensing technologies, leading to the development of customized drone solutions.

Agriculture Drone Market Driver: Availability of software solutions for field survey and data analytics

Software in drones acts as an interface for mediating the interaction between user and aircraft, and aircraft and its hardware. Similar to smartphones and tablet systems, choosing the wrong software platform for any drone can result in high switching costs if one needs to change the software in the future. Drone software is categorized as open source and proprietary software. Open-source software is distributed under a variety of licensing terms; almost anyone can modify the software to add capabilities that are not envisaged by its originators. Hence, it is preferred over proprietary software.

PX4 is one of the top open-source, auto-piloting software packages available from Pixhawk (Switzerland) in the agriculture drone sector. It is a piece of software that allows drones and other unmanned vehicles to fly. The software offers drone developers a versatile set of tools for sharing technology and creating customized solutions for drone applications. Farm surveying plays an important role in precision farming, along with proper analysis of field data collected by drones.

Agriculture Drones Market Share

The key players in this include DJI (China), PrecisionHawk (US), Trimble Inc. (US), Parrot Drones (France), AeroVironment, Inc. (US), Yamaha Motor Co., Ltd. (Japan), AgEagle Aerial Systems, Inc. (US), DroneDeploy (US), 3DR (US), and Sentera Inc. (US) SlantRange (US), Sentera Inc. (US), ATMOS UAV (Netherlands), Delair (France), and Nileworks Inc. (Japan).

The Asia Pacific market is projected to contribute the largest share of the agriculture drones market.

APAC is among the prospective markets for agriculture drones. APAC has large farmlands and a high population growth rate. APAC has a huge regional spread with countries such as China, Japan, India, Australia, New Zealand, and the Rest of APAC. In APAC, the adoption of agriculture drones is driven by factors such as the rising food demand, the need to improve yields despite limited resources, and the growing necessity to protect crops from unpredictable weather conditions.

Key Questions Addressed by Agriculture Drone Market Report:

1. What are the drivers for the growth of the agriculture drones market?

2. Which are the major companies in the agriculture drones market? What are their major strategies to strengthen their market presence?

3. Which region is expected to hold the highest share in the agriculture drones market?

4. Which are the key technology trends prevailing in the agriculture drones market?

5. What is the total CAGR expected to be recorded for the agriculture drones market during 2023-2028?

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/agriculture-drones-market-23709764.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Agriculture Drones Market Analysis, Trends, Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast – 2028

LTCC Market and HTCC Market Analysis, Graph, Trends, Segmentations, Top Key Players, Geographical Expansion, Key Development and Forecast

“Browse 73 market data Tables and 48 Figures spread through 119 Pages and in-depth TOC on “LTCC Market and HTCC Market””
LTCC Market and HTCC Market by Process Type (LTCC, HTCC), Material Type (Glass-Ceramic, Ceramic), End-use Industry (Automotive, Telecommunications, Aerospace & Defense, Medical), Region (Asia Pacific, North America, Europe, MEA, LA) – Global Forecast

The report “LTCC Market and HTCC Market by Process Type (LTCC, HTCC), Material Type (Glass-Ceramic, Ceramic), End-use Industry (Automotive, Telecommunications, Aerospace & Defense, Medical), Region (Asia Pacific, North America, Europe, MEA, LA) – Global Forecast to 2024″, is expected to grow from USD 916 million in 2019 to USD 1.1 billion by 2024, at a CAGR of 4.5% during the forecast period. The market is witnessing significant growth because of the growing demand from various end-use industries such as aerospace & defense, automotive, and telecommunications. Co-fired ceramic has good mechanical properties, such as excellent physical, chemical inactivity, hermicity, and high thermal stability properties.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126252032 

Automotive was the largest end-user industry in 2019

The automotive end-use industry requires co-fired ceramics to have more functionality in electronic devices, electronic packaging solutions to be smaller, lighter, more complex, operate at higher frequencies, and accommodate more components per unit area. Co-fired ceramics are used mainly for their superior properties such as excellent physical, chemical inactivity, hermicity, and high thermal stability properties. The thermal stability properties of co-fired ceramic help manufacturers in increasing the overall efficiency of automotive.

LTCC process type is the fastest-growing segment in the overall market.

Co-fired ceramic is available in two process types, namely, LTCC (Low-Temperature Co-Fired Ceramic), and HTCC (High-Temperature Co-Fired Ceramic). LTCC process type is expected to register the highest CAGR during the forecast period as it is used in various applications such as high radio frequency, wireless devices, antennas, and radar.

Glass-ceramic material type is the fastest-growing segment in the overall market.

Co-fired ceramic is available in two material types, namely, glass-ceramic and ceramic. Glass-ceramic material is expected to register the highest CAGR during the forecast period as it can use noble metals such as gold, silver, and platinum for metallization on its layer.

The Asia Pacific is expected to be the largest market for co-fired ceramic during the forecast period.

The Asia Pacific is one of the leading LTCC market and HTCC market. The growing demand from end-use industries such as aerospace & defense, automotive, and telecommunications is driving the LTCC market and HTCC market in the region. The region has a presence of major co-fired ceramic manufacturers who focus on the adoption of various business strategies to increase the production of co-fired ceramic and meet the growing demand from end users. For instance, KOA Corporation acquired VIA Electronic GmbH to extend its LTCC market and HTCC market in Japan, in June 2017.  

Some of the prominent players in the LTCC market and HTCC market are KYOCERA Corporation (Japan), DowDuPont Inc. (US), Murata Manufacturing Co., Ltd. (Japan), KOA Corporation (Japan), TDK Corporation (Japan), Hitachi Metals, Ltd. (Japan), Yokowo Co., Ltd. (Japan), NGK SPARK PLUG CO., LTD. (Japan), MARUWA Co., Ltd. (Japan), Micro Systems Technologies (Switzerland), and NIKKO COMPANY (Japan). The strategies undertaken by these players include partnerships, new product developments, and acquisition.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=126252032 

KYOCERA Corporation (Japan) is a well-established company in the global LTCC market and HTCC market. The company offers a high-quality, co-fired ceramic product. It is continuously engaged in providing high-grade, co-fired ceramic products. As a part of its growth strategy, it is focused highly on new product development and partnership. For instance, in 2018, the company developed an ultra-small ceramic package using Low-Temperature Co-Fired Ceramic for the high-frequency antenna.

Murata Manufacturing Co., Ltd. (Japan) is another major manufacturer of co-fired ceramics. It is one of the global leaders in the design, manufacture, and supply of advanced electronic material, leading-edge electronic components, and multi-functional, high-density modules. As a part of its growth strategy, the company strives to increase its profitability and provide quality products to long-term strategic customers. The company is an expert in creating innovative products and solutions for the electronics industry. It offers low-temperature co-fired ceramic multilayer substrates for the LTCC market and HTCC market. The product uses silver or copper for metallization path. It is also recognized as glass ceramics because of the mixture of glass with primary raw material, alumina. It caters to demand from automotive end-use industry. The product has applications in the anti-lock brake system, electronic stability control, electric power steering, and transmission control units.

Read Our Trending Press Release Below:

Silk Market

Decorative Paints & Coatings Market

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ltcc-htcc-market-126252032.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: LTCC Market and HTCC Market Analysis, Graph, Trends, Segmentations, Top Key Players, Geographical Expansion, Key Development and Forecast

Ulcerated Necrobiosis Lipoidica Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Processa Pharmaceuticals

“Ulcerated Necrobiosis Lipoidica Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Ulcerated Necrobiosis Lipoidica, historical and forecasted epidemiology as well as the Ulcerated Necrobiosis Lipoidica market trends in the 7MM.

DelveInsight’s “Ulcerated Necrobiosis Lipoidica Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Ulcerated Necrobiosis Lipoidica, historical and forecasted epidemiology as well as the Ulcerated Necrobiosis Lipoidica market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Ulcerated Necrobiosis Lipoidica market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Ulcerated Necrobiosis Lipoidica Market Forecast

 

Some of the key facts of the Ulcerated Necrobiosis Lipoidica Market Report: 

  • The Ulcerated Necrobiosis Lipoidica market size was valued approximately USD 35 million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • There were 254,858 diagnosed prevalent cases of Necrobiosis Lipoidica (NL) in the 7MM in 2021
  • The total number of diagnosed prevalent cases of UNL in the 7MM is anticipated to reach 87,467 in 2021 and may increase to 2032 at a CAGR of 0.4%
  • The number of diagnosed prevalent UNL cases in the US was 49,330, the highest number in the 7MM, and is projected to increase at a CAGR of 0.7%
  • Ulcerated Necrobiosis Lipoidica was detected in 28,596 instances in the EU-5 in 2021, accounting for an estimated 33% of all cases in the 7MM. It is expected that this number will continue to climb.
  • In 2021, Germany had the greatest diagnosed prevalence of UNL among the European nations (8,010 cases), followed by Spain (5,913 cases). In contrast, France (4,691 instances) had the lowest prevalence population that had been diagnosed among the EU-5 nations and the 7MM.
  • Key Ulcerated Necrobiosis Lipoidica Companies: Processa Pharmaceuticals, and others
  • Key Ulcerated Necrobiosis Lipoidica Therapies: PCS499, and others
  • The Ulcerated Necrobiosis Lipoidica market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Ulcerated Necrobiosis Lipoidica pipeline products will significantly revolutionize the Ulcerated Necrobiosis Lipoidica market dynamics.

 

Ulcerated Necrobiosis Lipoidica Overview

Necrobiosis lipoidica (NL), a rare chronic granulomatous skin condition of unknown etiology, manifests as inflammatory plaques that are yellow-brown in color with elevated borders and an atrophic center. Lesions are often bilateral and present on the anterior lower legs in NL.

 

Get a Free sample for the Ulcerated Necrobiosis Lipoidica Market Report: 

https://www.delveinsight.com/report-store/ulcerated-necrobiosis-lipoidica-market

 

Ulcerated Necrobiosis Lipoidica Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Ulcerated Necrobiosis Lipoidica Epidemiology Segmentation:

The Ulcerated Necrobiosis Lipoidica market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Ulcerated Necrobiosis Lipoidica
  • Prevalent Cases of Ulcerated Necrobiosis Lipoidica by severity
  • Gender-specific Prevalence of Ulcerated Necrobiosis Lipoidica
  • Diagnosed Cases of Episodic and Chronic Ulcerated Necrobiosis Lipoidica

 

Download the report to understand which factors are driving Ulcerated Necrobiosis Lipoidica epidemiology trends @ Ulcerated Necrobiosis Lipoidica Epidemiology Forecast

 

Ulcerated Necrobiosis Lipoidica Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ulcerated Necrobiosis Lipoidica market or expected to get launched during the study period. The analysis covers Ulcerated Necrobiosis Lipoidica market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Ulcerated Necrobiosis Lipoidica Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Ulcerated Necrobiosis Lipoidica Therapies and Key Companies

  • PCS499: Processa Pharmaceuticals

 

Discover more about therapies set to grab major Ulcerated Necrobiosis Lipoidica market share @ Ulcerated Necrobiosis Lipoidica Treatment Market

 

Ulcerated Necrobiosis Lipoidica Market Drivers

  • Rising patient population
  • Currently used off-label therapies lack evidence-based treatment
  • Ongoing development of PCS499

 

Ulcerated Necrobiosis Lipoidica Market Barriers

  • Challenges in the management of the disease
  • Unavailability of studies to estimate disease burden
  • High development cost

 

Scope of the Ulcerated Necrobiosis Lipoidica Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Ulcerated Necrobiosis Lipoidica Companies: Processa Pharmaceuticals, and others
  • Key Ulcerated Necrobiosis Lipoidica Therapies: PCS499, and others
  • Ulcerated Necrobiosis Lipoidica Therapeutic Assessment: Ulcerated Necrobiosis Lipoidica current marketed and Ulcerated Necrobiosis Lipoidica emerging therapies
  • Ulcerated Necrobiosis Lipoidica Market Dynamics: Ulcerated Necrobiosis Lipoidica market drivers and Ulcerated Necrobiosis Lipoidica market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Ulcerated Necrobiosis Lipoidica Unmet Needs, KOL’s views, Analyst’s views, Ulcerated Necrobiosis Lipoidica Market Access and Reimbursement 

 

To know more about Ulcerated Necrobiosis Lipoidica companies working in the treatment market, visit @ Ulcerated Necrobiosis Lipoidica Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Ulcerated Necrobiosis Lipoidica Market Report Introduction

2. Executive Summary for Ulcerated Necrobiosis Lipoidica

3. SWOT analysis of Ulcerated Necrobiosis Lipoidica

4. Ulcerated Necrobiosis Lipoidica Patient Share (%) Overview at a Glance

5. Ulcerated Necrobiosis Lipoidica Market Overview at a Glance

6. Ulcerated Necrobiosis Lipoidica Disease Background and Overview

7. Ulcerated Necrobiosis Lipoidica Epidemiology and Patient Population

8. Country-Specific Patient Population of Ulcerated Necrobiosis Lipoidica 

9. Ulcerated Necrobiosis Lipoidica Current Treatment and Medical Practices

10. Ulcerated Necrobiosis Lipoidica Unmet Needs

11. Ulcerated Necrobiosis Lipoidica Emerging Therapies

12. Ulcerated Necrobiosis Lipoidica Market Outlook

13. Country-Wise Ulcerated Necrobiosis Lipoidica Market Analysis (2019–2032)

14. Ulcerated Necrobiosis Lipoidica Market Access and Reimbursement of Therapies

15. Ulcerated Necrobiosis Lipoidica Market Drivers

16. Ulcerated Necrobiosis Lipoidica Market Barriers

17.  Ulcerated Necrobiosis Lipoidica Appendix

18. Ulcerated Necrobiosis Lipoidica Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ulcerated Necrobiosis Lipoidica Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Processa Pharmaceuticals

IgA Nephropathy Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, MOA, ROA by DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, IgA Nephropathy pipeline constitutes 30+ key companies continuously working towards developing 30+ IgA Nephropathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The IgA Nephropathy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

“IgA Nephropathy Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the IgA Nephropathy Market.

 

Some of the key takeaways from the IgA Nephropathy Pipeline Report:

  • Companies across the globe are diligently working toward developing novel IgA Nephropathy treatment therapies with a considerable amount of success over the years. 
  • IgA Nephropathy companies working in the treatment market are Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund Pharmaceuticals, Rohto Pharmaceutical, Wuhan Createrna Science and Technology, Guangdong Hengrui Pharmaceutical, LRx Ionis Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd., Travere Therapeutics, and others, are developing therapies for the IgA Nephropathy treatment 
  • Emerging IgA Nephropathy therapies in the different phases of clinical trials are- Sibeprenlimab, Atrasentan, LNP023, Research programme, AP 305, ADR-001, MY 008, SHR-2010, IONIS FB, HR19042, Sparsentan, HR19042, and others are expected to have a significant impact on the IgA Nephropathy market in the coming years.   
  • In January 2024, Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company in the advanced stages of clinical development focused on innovative treatments for individuals with severe immunologic conditions, announced today the addition of two seasoned industry professionals to spearhead the advancement of the company’s drug initiatives. This includes their late-stage candidate, atacicept, presently undergoing a Phase 3 clinical trial for IgA nephropathy (IgAN). Effective immediately, Robert M. Brenner, M.D., assumes the role of Chief Medical Officer, succeeding Dr. Celia Lin, M.D., while William D. Turner takes on the position of Chief Development Officer.
  • In June 2023, Chinook Therapeutics, Inc. has disclosed a merger agreement with Novartis AG, outlining Novartis’s acquisition of Chinook for $40 per share in cash, totaling $3.2 billion. This proposed offer reflects an 83% premium over Chinook’s 60-day volume-weighted average stock price and a 67% premium over Chinook’s closing price on June 9, 2023. Additionally, Chinook shareholders are set to receive contingent value rights (CVRs) allowing for payments of up to $4 per share based on the accomplishment of specific regulatory milestones for Chinook’s primary product candidate, atrasentan.
  • In November 2022, Chinook Therapeutics, Inc. (Nasdaq: KDNY), has revealed the showcasing of two posters and three informational posters at the current ASN Kidney Week 2022. The event is taking place in a virtual and live format in Orlando, Florida.

 

IgA Nephropathy Overview

IgA nephropathy, also known as Berger’s disease, is a kidney disorder characterized by the buildup of immunoglobulin A (IgA) antibodies in the kidneys. IgA is a type of antibody that helps the immune system fight infections. In IgA nephropathy, these antibodies build up in the glomeruli, which are tiny filtering units within the kidneys responsible for removing waste and excess fluids from the blood.

 

Get a Free Sample PDF Report to know more about IgA Nephropathy Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/iga-nephropathy-igan-pipeline-insight

 

Emerging IgA Nephropathy Drugs Under Different Phases of Clinical Development Include:

  • Sibeprenlimab: Visterra
  • Atrasentan: Chinook Therapeutics
  • LNP023: Novartis Pharmaceuticals
  • Research programme: IgA proteases Selecta Biosciences
  • AP 305: Shanghai Alebund Pharmaceuticals
  • ADR-001: Rohto Pharmaceutical
  • MY 008: Wuhan Createrna Science and Technology
  • SHR-2010: Guangdong Hengrui Pharmaceutical
  • IONIS FB: LRx Ionis Pharmaceuticals
  • HR19042: Jiangsu HengRui Medicine Co., Ltd.
  • Sparsentan: Travere Therapeutics
  • HR19042: Jiangsu HengRui Medicine Co., Ltd.

 

IgA Nephropathy Route of Administration

IgA Nephropathy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as 

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Topical

 

IgA Nephropathy Molecule Type

IgA Nephropathy Products have been categorized under various Molecule types, such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy 

 

IgA Nephropathy Pipeline Therapeutics Assessment

  • IgA Nephropathy Assessment by Product Type
  • IgA Nephropathy By Stage and Product Type
  • IgA Nephropathy Assessment by Route of Administration
  • IgA Nephropathy By Stage and Route of Administration
  • IgA Nephropathy Assessment by Molecule Type
  • IgA Nephropathy by Stage and Molecule Type

 

DelveInsight’s IgA Nephropathy Report covers around 30+ products under different phases of clinical development like

  • Late-stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I)
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates
  • Route of Administration

 

Further IgA Nephropathy product details are provided in the report. Download the IgA Nephropathy pipeline report to learn more about the emerging IgA Nephropathy therapies

 

Some of the key companies in the IgA Nephropathy Therapeutics Market include:

Key companies developing therapies for IgA Nephropathy are – Novartis, Omeros Corporation, Otsuka Pharmaceutical, Alnylam Pharmaceuticals, MorphoSys AG, Arrowhead Pharmaceuticals, Takeda, Chinook Therapeutics, Inc., RemeGen Co., Ltd., Novartis, Omeros Corporation, Otsuka Pharmaceutical, Alnylam Pharmaceuticals, MorphoSys AG, Rohto Pharmaceutical, Alexion Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd., Ionis Pharmaceuticals, Inc., Vera Therapeutics, Inc., Eledon Pharmaceuticals, Guangdong Hengrui Pharmaceutical Co., Ltd, Apellis Pharmaceuticals, Inc., and others.

 

IgA Nephropathy Pipeline Analysis:

The IgA Nephropathy pipeline report provides insights into 

  • The report provides detailed insights about companies that are developing therapies for the treatment of IgA Nephropathy with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for IgA Nephropathy Treatment.
  • IgA Nephropathy key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • IgA Nephropathy Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the IgA Nephropathy market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

 

Download Sample PDF Report to know more about IgA Nephropathy drugs and therapies

 

IgA Nephropathy Pipeline Market Drivers

  • Increase in prevalence of IgA Nephropathy (IgAN), increment in the number of government initiatives to spread awareness are some of the important factors that are fueling the IgA Nephropathy Market.

 

IgA Nephropathy Pipeline Market Barriers

  • However, lack of in-depth understanding of the disease pathogenesis, the unreported and undiagnosed IgA Nephropathy cases and other factors are creating obstacles in the IgA Nephropathy Market growth.

 

Scope of IgA Nephropathy Pipeline Drug Insight    

  • Coverage: Global
  • Key IgA Nephropathy Companies: Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund Pharmaceuticals, Rohto Pharmaceutical, Wuhan Createrna Science and Technology, Guangdong Hengrui Pharmaceutical, LRx Ionis Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd., Travere Therapeutics, and others
  • Key IgA Nephropathy Therapies: Sibeprenlimab, Atrasentan, LNP023, Research programme, AP 305, ADR-001, MY 008, SHR-2010, IONIS FB, HR19042, Sparsentan, HR19042, and others
  • IgA Nephropathy Therapeutic Assessment: IgA Nephropathy current marketed and IgA Nephropathy emerging therapies
  • IgA Nephropathy Market Dynamics: IgA Nephropathy market drivers and IgA Nephropathy market barriers 

 

Request for Sample PDF Report for IgA Nephropathy Pipeline Assessment and clinical trials

 

Table of Contents

1. IgA Nephropathy Report Introduction

2. IgA Nephropathy Executive Summary

3. IgA Nephropathy Overview

4. IgA Nephropathy- Analytical Perspective In-depth Commercial Assessment

5. IgA Nephropathy Pipeline Therapeutics

6. IgA Nephropathy Late Stage Products (Phase II/III)

7. IgA Nephropathy Mid Stage Products (Phase II)

8. IgA Nephropathy Early Stage Products (Phase I)

9. IgA Nephropathy Preclinical Stage Products

10. IgA Nephropathy Therapeutics Assessment

11. IgA Nephropathy Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. IgA Nephropathy Key Companies

14. IgA Nephropathy Key Products

15. IgA Nephropathy Unmet Needs

16 . IgA Nephropathy Market Drivers and Barriers

17. IgA Nephropathy Future Perspectives and Conclusion

18. IgA Nephropathy Analyst Views

19. Appendix

20. About DelveInsight

 

 

About DelveInsight

 

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: IgA Nephropathy Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, MOA, ROA by DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences

Duchenne Muscular Dystrophy Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Vertex Pharma, Bioleaders Corporation, Wave Life Science

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Duchenne Muscular Dystrophy pipeline constitutes 75+ key companies continuously working towards developing 75+ Duchenne Muscular Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Duchenne Muscular Dystrophy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

“Duchenne Muscular Dystrophy Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Duchenne Muscular Dystrophy Market.

 

Some of the key takeaways from the Duchenne Muscular Dystrophy Pipeline Report: 

  • Companies across the globe are diligently working toward developing novel Duchenne Muscular Dystrophy treatment therapies with a considerable amount of success over the years. 
  • Duchenne Muscular Dystrophy companies working in the treatment market are Vertex Pharmaceuticals, Bioleaders Corporation, Wave Life Sciences Ltd., REGENXBIO Inc., Daiichi Sankyo, Sarepta Therapeutics, Taiho Pharmaceutical, FibroGen, Santhera, Italfarmaco, Roche/Sarepta Therapeutics, Edgewise Therapeutics, Sarepta Therapeutics, Wave Life Sciences Ltd, PepGen, Ultragenyx Pharmaceutical, and others, are developing therapies for the Duchenne Muscular Dystrophy treatment 
  • Emerging Duchenne Muscular Dystrophy therapies in the different phases of clinical trials are- CRISPR editing therapy, BLS-M22, WVE-N531, RGX-202, DS-5141, SRP-5051, TAS-205, Pamrevlumab, Vamorolone, Givinostat, Delandistrogene moxeparvovec, EDG 5506, SRP-5051, WVE N531, PGN EDO51, UX810, and others are expected to have a significant impact on the Duchenne Muscular Dystrophy market in the coming years.   
  • In July 2022, The Phase III HOPE-3 clinical trial of Capricor Therapeutics’ cell treatment, CAP-1002, to treat late-stage Duchenne muscular dystrophy (DMD), dosed its first participant.
  • In June 2022, For its current Phase III LELANTOS-2 clinical study (NCT04632940) of pamrevlumab, a first-in-class connective tissue growth factor (CTGF) inhibitor antibody, in patients with Duchenne muscular dystrophy (DMD), FibroGen said that it had reached its target enrollment goal. Once the trial has enrolled all 73 Duchenne muscular dystrophy patients between the ages of 6 and 12 who were intended to participate, topline data will be read out in the second half of 2023.
  • In May 2022, Elamipretide has been designated as an orphan medication by the FDA for the treatment of Duchenne muscular dystrophy, according to a statement from Stealth BioTherapeutics.
  • In January 2022, The US Food and Drug Administration (FDA) has given Regenxbio permission to begin a Phase I/II clinical trial in the US to assess the security and effectiveness of RGX-202, an investigational gene therapy for Duchenne muscular dystrophy (DMD).

 

Duchenne Muscular Dystrophy Overview

The most prevalent genetic neuromuscular condition that affects people of all racial and ethnic backgrounds is Duchenne muscular dystrophy. Only men are affected; it affects 1/3,600 live births of infant boys. Some affected neonates may exhibit moderate hypotonia, but further symptoms are rarely noticeable at birth or throughout the first few months of life.

 

Get a Free Sample PDF Report to know more about Duchenne Muscular Dystrophy Pipeline Therapeutic Assessment- 

https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-pipeline-insight

 

Emerging Duchenne Muscular Dystrophy Drugs Under Different Phases of Clinical Development Include:

  • Pamrevlumab: FibroGen
  • Vamorolone: Santhera
  • Givinostat: Italfarmaco
  • Delandistrogene moxeparvovec: Roche/Sarepta Therapeutics
  • CRISPR editing therapy: Vertex Pharmaceuticals
  • BLS-M22: Bioleaders Corporation
  • WVE-N531: Wave Life Sciences Ltd.
  • RGX-202: REGENXBIO Inc.
  • DS-5141: Daiichi Sankyo
  • SRP-5051: Sarepta Therapeutics
  • TAS-205: Taiho Pharmaceutical
  • EDG 5506: Edgewise Therapeutics
  • SRP-5051: Sarepta Therapeutics
  • WVE N531: Wave Life Sciences Ltd
  • PGN EDO51: PepGen
  • UX810: Ultragenyx Pharmaceutical

 

Duchenne Muscular Dystrophy Route of Administration

Duchenne Muscular Dystrophy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as 

  • Oral
  • Intravenous
  • Subcutaneous

 

Duchenne Muscular Dystrophy Molecule Type

Duchenne Muscular Dystrophy Products have been categorized under various Molecule types, such as

  • Cell Therapy
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

 

Duchenne Muscular Dystrophy Pipeline Therapeutics Assessment

  • Duchenne Muscular Dystrophy Assessment by Product Type
  • Duchenne Muscular Dystrophy By Stage and Product Type
  • Duchenne Muscular Dystrophy Assessment by Route of Administration
  • Duchenne Muscular Dystrophy By Stage and Route of Administration
  • Duchenne Muscular Dystrophy Assessment by Molecule Type
  • Duchenne Muscular Dystrophy by Stage and Molecule Type

 

DelveInsight’s Duchenne Muscular Dystrophy Report covers around 75+ products under different phases of clinical development like

  • Late-stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I)
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates
  • Route of Administration

 

Further Duchenne Muscular Dystrophy product details are provided in the report. Download the Duchenne Muscular Dystrophy pipeline report to learn more about the emerging Duchenne Muscular Dystrophy therapies

 

Some of the key companies in the Duchenne Muscular Dystrophy Therapeutics Market include:

Key companies developing therapies for Duchenne Muscular Dystrophy are – Santhera Pharmaceuticals, Sarepta Therapeutics, Italfarmaco, Wave Life Sciences Ltd, FibroGen, Edgewise Therapeutics, Pfizer, Daiichi Sankyo, Sarepta Therapeutics, Inc., ENCell, Taiho Pharmaceutical, Solid Biosciences, Capricor, Nippon Shinyaku, Hansa Biopharma, Ultragenyx Pharmaceutical, Dyne Therapeutics, Entrada Therapeutics, AAVogen, PepGen, Antisense Therapeutics, BioMarin Pharmaceutical, Avidity Biosciences, Sarepta Therapeutics, Dyne Therapeutics, Solid Biosciences Inc, Regenxbio, Stealth BioTherapeutics, and others.

 

Duchenne Muscular Dystrophy Pipeline Analysis:

The Duchenne Muscular Dystrophy pipeline report provides insights into 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Duchenne Muscular Dystrophy with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Duchenne Muscular Dystrophy Treatment.
  • Duchenne Muscular Dystrophy key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Duchenne Muscular Dystrophy Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Duchenne Muscular Dystrophy market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

 

Download Sample PDF Report to know more about Duchenne Muscular Dystrophy drugs and therapies

 

Duchenne Muscular Dystrophy Pipeline Market Drivers

  • Robust Duchenne Muscular Dystrophy pipeline, development of Mutation Suppression therapies are some of the important factors that are fueling the Duchenne Muscular Dystrophy Market.

 

Duchenne Muscular Dystrophy Pipeline Market Barriers

  • However, high cost of Duchenne Muscular Dystrophy treatments, regulatory procedure & and lack of standardized protocol and other factors are creating obstacles in the Duchenne Muscular Dystrophy Market growth.

 

Scope of Duchenne Muscular Dystrophy Pipeline Drug Insight    

  • Coverage: Global
  • Key Duchenne Muscular Dystrophy Companies: Vertex Pharmaceuticals, Bioleaders Corporation, Wave Life Sciences Ltd., REGENXBIO Inc., Daiichi Sankyo, Sarepta Therapeutics, Taiho Pharmaceutical, FibroGen, Santhera, Italfarmaco, Roche/Sarepta Therapeutics, Edgewise Therapeutics, Sarepta Therapeutics, Wave Life Sciences Ltd, PepGen, Ultragenyx Pharmaceutical, and others
  • Key Duchenne Muscular Dystrophy Therapies: CRISPR editing therapy, BLS-M22, WVE-N531, RGX-202, DS-5141, SRP-5051, TAS-205, Pamrevlumab, Vamorolone, Givinostat, Delandistrogene moxeparvovec, EDG 5506, SRP-5051, WVE N531, PGN EDO51, UX810, and others
  • Duchenne Muscular Dystrophy Therapeutic Assessment: Duchenne Muscular Dystrophy current marketed and Duchenne Muscular Dystrophy emerging therapies
  • Duchenne Muscular Dystrophy Market Dynamics: Duchenne Muscular Dystrophy market drivers and Duchenne Muscular Dystrophy market barriers 

 

Request for Sample PDF Report for Duchenne Muscular Dystrophy Pipeline Assessment and clinical trials

 

Table of Contents

1. Duchenne Muscular Dystrophy Report Introduction

2. Duchenne Muscular Dystrophy Executive Summary

3. Duchenne Muscular Dystrophy Overview

4. Duchenne Muscular Dystrophy- Analytical Perspective In-depth Commercial Assessment

5. Duchenne Muscular Dystrophy Pipeline Therapeutics

6. Duchenne Muscular Dystrophy Late Stage Products (Phase II/III)

7. Duchenne Muscular Dystrophy Mid Stage Products (Phase II)

8. Duchenne Muscular Dystrophy Early Stage Products (Phase I)

9. Duchenne Muscular Dystrophy Preclinical Stage Products

10. Duchenne Muscular Dystrophy Therapeutics Assessment

11. Duchenne Muscular Dystrophy Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Duchenne Muscular Dystrophy Key Companies

14. Duchenne Muscular Dystrophy Key Products

15. Duchenne Muscular Dystrophy Unmet Needs

16 . Duchenne Muscular Dystrophy Market Drivers and Barriers

17. Duchenne Muscular Dystrophy Future Perspectives and Conclusion

18. Duchenne Muscular Dystrophy Analyst Views

19. Appendix

20. About DelveInsight

 

About DelveInsight

 

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Duchenne Muscular Dystrophy Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Vertex Pharma, Bioleaders Corporation, Wave Life Science